D-0854-2018 Class II Terminated
FDA drug recall D-0854-2018 was initiated by PharMEDium Services, LLC on Jun 5, 2018 and is designated Class II. Reason for recall: Superpotent and Subpotent The recall status is terminated (terminated Feb 6, 2019). Affected quantity: 2,800 syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- Jun 20, 2018
- Initiation Date
- Jun 5, 2018
- Termination Date
- Feb 6, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,800 syringes
Product Description
HYDROmorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride, 1 mL Total Volume in 3 mL syringe, Rx, PharMEDium Services, LLC, Dayton, NJ
Reason for Recall
Superpotent and Subpotent
Distribution Pattern
Nationwide
Code Information
Lot numbers: 180820005D, exp 6/21/2018; 180990007D, exp 7/8/2018; and 181000020D, exp 7/9/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0854-2018
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 26, 2026